Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001415889-19-001066)

Filing Details

Accession Number:: 0001415889-19-001066
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2019-09-19 16:05:15
Reporting Period:: 2019-09-18

Accepted Time:: 2019-09-19 16:05:15
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
816284	Celgene Corp	CELG	Pharmaceutical Preparations (2834)	222711928

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1690298	Terrie Curran	C/O Celgene Corporation 86 Morris Avenue Summit NJ 07901	See Remarks	No	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2019-09-18	4,500	$58.33	13,493	No	4	M	Direct
Common Stock	Disposition	2019-09-18	4,500	$98.20	8,993	No	4	S	Direct
Common Stock	Disposition	2019-09-18	6,838	$98.31	2,155	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (right to buy)	Disposition	2019-09-18	4,500	$0.00	4,500	$58.33

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
2,072		2023-05-01	No	4	M	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	926	Indirect	401(k) Plan

Footnotes

The option was fully exercisable.
The option was issued pursuant to the Company's 2017 Stock Incentive Plan (formerly known as the Company's 2008 Stock Incentive Plan).